Wayland Group Corp. (MRRCF)

USD 0.0

(0.0%)

Market Cap (In USD)

23.7 Thousand

Revenue (In USD)

2.48 Million

Net Income (In USD)

-51.62 Million

Avg. Volume

-

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
1.0E-6-1.0E-4
PE
-
EPS
-
Beta Value
-44.344
ISIN
CA9442041062
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. David Miller
Employee Count
-
Website
https://www.waylandgroup.com
Ipo Date
2001-05-07
Details
Wayland Group Corp. produces and sells medical and non-medical cannabis for cannabis patients and consumers in Canada and internationally. It offers a range of CBD, balanced, and THC strains under the Kiwi, Northern Harvest, High Tide, Lost at Seed, Solara C, Rare Dankness, and Maricann names. The company was founded in 2013 and is headquartered in Oakville, Canada. Wayland Group Corp. is a subsidiary of Maricann Group Inc.